| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Chief Financial Officer | Common Stock, $0.0001 Par Value | 28,661 | $7,509 | $0.2620 | 31 Dec 2025 | Direct |
| INTENSITY THERAPEUTICS, INC. | Chief Financial Officer | Stock Option (right to buy Common Stock) | 300,000 | 02 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INTS | INTENSITY THERAPEUTICS, INC. | 31 Dec 2025 | 1 | +$3,794 | 4 | Chief Financial Officer | 05 Jan 2026, 16:01 |
| INTS | INTENSITY THERAPEUTICS, INC. | 30 Jun 2025 | 1 | +$3,701 | 4 | Chief Financial Officer | 02 Jul 2025, 16:02 |
| INTS | INTENSITY THERAPEUTICS, INC. | 02 May 2025 | 1 | $0 | 4 | Chief Financial Officer | 06 May 2025, 16:03 |
| INTS | INTENSITY THERAPEUTICS, INC. | 21 Oct 2024 | 1 | $0 | 4 | Chief Financial Officer | 23 Oct 2024, 16:21 |
| INTS | INTENSITY THERAPEUTICS, INC. | 11 Dec 2023 | 1 | $0 | 4 | Chief Financial Officer | 12 Dec 2023, 08:17 |
| INTS | INTENSITY THERAPEUTICS, INC. | 11 Dec 2023 | 0 | $0 | 3 | Chief Financial Officer | 12 Dec 2023, 08:15 |